Recombinant Human CST2 Protein，His

CST2 (Cystatin SN) is a member of the cystatin superfamily of cysteine protease inhibitors, which play important roles in various physiological and pathological processes. Research on CST2 has gained attention due to its potential implications in neurodegenerative diseases, inflammation, and cancer. Initially identified as a neuroprotective factor, CST2 has been shown to modulate proteolytic activity in the brain, suggesting its role in maintaining protein homeostasis and protecting neurons from excessive proteolysis. The interest in CST2 has also been fueled by its differential expression patterns observed in various tissue types and disease states. For example, elevated levels of CST2 have been linked to certain tumors, indicating its potential as a biomarker for cancer progression. Furthermore, the understanding of CST2's interactions with other cellular proteins and its regulatory mechanisms can provide insights into its functional role within the cell. The ability to produce recombinant CST2 protein allows for detailed biophysical and biochemical studies, enabling researchers to explore its structure-function relationships and therapeutic applications. Overall, the investigation of CST2 recombinant protein not only enhances our understanding of its biological roles but also opens avenues for developing novel diagnostic and therapeutic strategies in various diseases.